Campath
Plasma Cell Dyscrasia
Baylor College of MedicinePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
21 Active assets in the Plasma Cell Dyscrasia cohort.
View all 50 →
Same molecule, other indications
Campath is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →